IROA Technologies LLC evolved from NextGen Metabolomics which was established in June 2010.  The Company founders have had a career of pioneering metabolomics platforms, drug development and life technologies. The continuing metabolomics challenge, despite the evolution of mass spectrometry platforms, is the identification and interpretation of vast datasets.

IROA methodologies eliminate noise, analytical variability and ion suppression making it easy to achieve clean, accurate, reproducible datasets. Sophisticated IROA-aware algorithms turn these datasets into solutions by providing insights into their meaning.

The mission of IROA Technologies is to simplify our customer’s metabolomics research. We continue to develop products that streamline biomarker discovery.